Daniel T. Mytych

1.2k total citations
42 papers, 796 citations indexed

About

Daniel T. Mytych is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Daniel T. Mytych has authored 42 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 19 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Hematology. Recurrent topics in Daniel T. Mytych's work include Biosimilars and Bioanalytical Methods (20 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Blood groups and transfusion (8 papers). Daniel T. Mytych is often cited by papers focused on Biosimilars and Bioanalytical Methods (20 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Blood groups and transfusion (8 papers). Daniel T. Mytych collaborates with scholars based in United States, United Kingdom and Sweden. Daniel T. Mytych's co-authors include Steven J. Swanson, John Ferbas, Arunan Kaliyaperumal, Michael C. Mullenix, James A. Lofgren, Vibha Jawa, Narendra Chirmule, Mark A. Kroenke, Vincent Chow and Mirna Koscec and has published in prestigious journals such as Blood, The Journal of Immunology and The Journal of Organic Chemistry.

In The Last Decade

Daniel T. Mytych

42 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel T. Mytych United States 16 427 374 333 148 86 42 796
Bas C. Jansen Netherlands 17 415 1.0× 466 1.2× 933 2.8× 64 0.4× 53 0.6× 29 1.3k
Amita Datta‐Mannan United States 18 294 0.7× 828 2.2× 832 2.5× 244 1.6× 41 0.5× 37 1.2k
Remco Visser Netherlands 12 496 1.2× 577 1.5× 558 1.7× 47 0.3× 233 2.7× 30 1.0k
Nicolas Bihoreau France 18 166 0.4× 403 1.1× 561 1.7× 70 0.5× 205 2.4× 38 913
Huaizu Guo China 18 415 1.0× 371 1.0× 492 1.5× 257 1.7× 27 0.3× 41 988
Shannon Marshall United States 21 283 0.7× 250 0.7× 726 2.2× 320 2.2× 32 0.4× 40 1.2k
Mary Brummet United States 22 365 0.9× 452 1.2× 355 1.1× 369 2.5× 36 0.4× 47 1.3k
Rosina Plomp Netherlands 16 626 1.5× 768 2.1× 915 2.7× 43 0.3× 133 1.5× 20 1.3k
Michael Curcio United States 12 301 0.7× 907 2.4× 296 0.9× 592 4.0× 51 0.6× 16 1.4k
Agnes L. Hipgrave Ederveen Netherlands 19 400 0.9× 348 0.9× 721 2.2× 41 0.3× 158 1.8× 33 1.0k

Countries citing papers authored by Daniel T. Mytych

Since Specialization
Citations

This map shows the geographic impact of Daniel T. Mytych's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel T. Mytych with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel T. Mytych more than expected).

Fields of papers citing papers by Daniel T. Mytych

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel T. Mytych. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel T. Mytych. The network helps show where Daniel T. Mytych may publish in the future.

Co-authorship network of co-authors of Daniel T. Mytych

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel T. Mytych. A scholar is included among the top collaborators of Daniel T. Mytych based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel T. Mytych. Daniel T. Mytych is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulasekararaj, Austin, Francesco Lanza, Saskia Langemeijer, et al.. (2024). Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria. American Journal of Hematology. 99(11). 2108–2117. 4 indexed citations
2.
Semple, John W., et al.. (2024). Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment. Blood Reviews. 67. 101222–101222. 5 indexed citations
3.
Chow, Vincent, Daniel T. Mytych, Andrew Blauvelt, et al.. (2024). P1081 Pharmacokinetics and immunogenicity of the ustekinumab biosimilar candidate ABP 654 in patients with moderate-to-severe plaque psoriasis. Journal of Crohn s and Colitis. 18(Supplement_1). i1932–i1932. 2 indexed citations
4.
5.
Penny, Hweixian Leong, Bin Wu, Christian Brandl, et al.. (2023). Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy. Frontiers in Immunology. 14. 1261070–1261070. 10 indexed citations
6.
Chow, Vincent, Daniel T. Mytych, Shyamal Kumar Das, & Janet Franklin. (2023). Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double‐blind Study in Healthy Subjects. Clinical Pharmacology in Drug Development. 12(9). 863–873. 13 indexed citations
7.
Zhou, Yanchen, Feng Zhang, Zheng Hu, et al.. (2022). Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions. Cephalalgia. 42(8). 749–760. 8 indexed citations
8.
Henry, Scott P., Cecilia Arfvidsson, David Crowe, et al.. (2022). Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs. Nucleic Acid Therapeutics. 32(5). 369–377. 8 indexed citations
9.
Kroenke, Mark A., Jenny Hu, Lidong He, et al.. (2021). Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target. Frontiers in Immunology. 12. 782788–782788. 8 indexed citations
10.
Jawa, Vibha, et al.. (2018). Assessment of Romiplostim Immunogenicity in Adult Patients in Clinical Trials and in a Global Registry. Blood. 132(Supplement 1). 2427–2427. 3 indexed citations
11.
Mytych, Daniel T., M. Benjamin Hock, Mark A. Kroenke, et al.. (2017). A Proposal to Redefine Clinical Immunogenicity Assessment. The AAPS Journal. 19(3). 599–602. 6 indexed citations
12.
Wadhwa, Meenu, Daniel T. Mytych, Chris Bird, et al.. (2016). Establishment of the first WHO Erythropoietin antibody reference panel: Report of an international collaborative study. Journal of Immunological Methods. 435. 32–42. 11 indexed citations
13.
Gow, Jason M., Wayne Tsuji, Gary J. Williams, et al.. (2015). Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects. Arthritis Research & Therapy. 17(1). 282–282. 22 indexed citations
14.
Lebrec, Hervé, Darrell R. Boverhof, Mark Collinge, et al.. (2014). The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: Study design, data analysis, interpretation. Regulatory Toxicology and Pharmacology. 69(1). 7–21. 31 indexed citations
15.
16.
Lebrec, Hervé, M. Benjamin Hock, John S. Sundsmo, et al.. (2013). T-cell-dependent antibody responses in the rat: Forms and sources of keyhole limpet hemocyanin matter. Journal of Immunotoxicology. 11(3). 213–221. 13 indexed citations
17.
Mytych, Daniel T., Chadwick King, Raj Haldankar, et al.. (2012). Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing. Journal of Immunological Methods. 382(1-2). 129–141. 15 indexed citations
18.
Sánchez-Nuño, Sergio, Lei Zhou, Michael Hale, et al.. (2011). Strategy to confirm the presence of anti-erythropoietin neutralizing antibodies in human serum. Journal of Pharmaceutical and Biomedical Analysis. 55(5). 1265–1274. 16 indexed citations
19.
Koren, Eugen, Anne S. De Groot, Vibha Jawa, et al.. (2007). Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein. Clinical Immunology. 124(1). 26–32. 100 indexed citations
20.
Mytych, Daniel T., et al.. (2003). Validation of the BIACORE 3000 platform for detection of antibodies against erythropoietic agents in human serum samples. Current Medical Research and Opinion. 19(7). 651–659. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bas C. Jansen Breakdown of academic impact, for papers by Amita Datta‐Mannan Breakdown of academic impact, for papers by Remco Visser Breakdown of academic impact, for papers by Nicolas Bihoreau Breakdown of academic impact, for papers by Huaizu Guo Breakdown of academic impact, for papers by Shannon Marshall Breakdown of academic impact, for papers by Mary Brummet Breakdown of academic impact, for papers by Rosina Plomp Breakdown of academic impact, for papers by Michael Curcio Breakdown of academic impact, for papers by Agnes L. Hipgrave Ederveen
Rankless by CCL
2026